Main Session
Sep
29
SS 27 - Breast Cancer 2: Multimodal Strategies in Breast Cancer: Biology, Systemic Therapy, and Psychosocial Insights
262 - Safety and potential radiosensitizing effect of Olaparib in combination with breast radiotherapy for TNBC patients with residual disease: long-term results from a phase I trial
Presenter(s)
Pierre Loap, MD - Institut Curie, Paris,